differenza tra tirzepatide e semaglutide Semaglutide, tumori: aumentano il rischio? Dati 2026 - Obesità GLP-1, semaglutide e tirzepatide: si

Food and Drug Administration granted approval for Wegovy (semaglutide) injection at a 2.4 mg dosage, administered once weekly

Suspected adverse reactions to any medication should be reported through the MHRA Yellow Card scheme

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

All treatment decisions should be made with a qualified healthcare provider who can evaluate the benefits and risks of any weight management approach based on individual clinical needs

How to Preserve Muscle While Losing Weight Preserving muscle mass during weight loss requires a multi-faceted approach